Market Closed -
Nyse
16:00:02 2024-05-21 EDT
|
5-day change
|
1st Jan Change
|
42.32
USD
|
-0.09%
|
|
+4.01%
|
-8.00%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,501
|
5,773
|
5,338
|
-
|
Enterprise Value (EV)
1 |
2,655
|
5,773
|
5,338
|
5,338
|
P/E ratio
|
4.79
x
|
-97.9
x
|
9.36
x
|
8.12
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.07
x
|
1.28
x
|
0.9
x
|
0.91
x
|
EV / Revenue
|
1.07
x
|
1.28
x
|
0.9
x
|
0.91
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
3,824,542
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.39
x
|
-
|
1.54
x
|
1.34
x
|
Nbr of stocks (in thousands)
|
125,000
|
125,497
|
126,139
|
-
|
Reference price
2 |
20.01
|
46.00
|
42.32
|
42.32
|
Announcement Date
|
23-02-22
|
24-02-21
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,113
|
2,340
|
4,500
|
5,954
|
5,838
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
510
|
-
|
-
|
-
|
-
|
Operating Margin
|
24.14%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
568
|
598
|
-35
|
688
|
819
|
Net income
1 |
476
|
481
|
-58
|
560
|
647
|
Net margin
|
22.53%
|
20.56%
|
-1.29%
|
9.41%
|
11.08%
|
EPS
2 |
-
|
4.180
|
-0.4700
|
4.520
|
5.210
|
Free Cash Flow
|
-
|
654
|
-
|
-
|
-
|
FCF margin
|
-
|
27.95%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
135.97%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-26
|
23-02-22
|
24-02-21
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
623
|
869
|
1,168
|
851
|
1,612
|
1,569
|
1,228
|
1,480
|
1,700
|
1,369
|
1,409
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-176
|
-203
|
163
|
380
|
-375
|
142
|
180
|
190
|
198
|
187
|
198
|
Net income
1 |
115
|
-100
|
-195
|
130
|
306
|
-299
|
111
|
142
|
150
|
157
|
-
|
-
|
Net margin
|
-
|
-16.05%
|
-22.44%
|
11.13%
|
35.96%
|
-18.55%
|
7.07%
|
11.56%
|
10.14%
|
9.24%
|
-
|
-
|
EPS
2 |
0.7600
|
-0.8000
|
-1.560
|
1.040
|
2.450
|
-2.410
|
0.8800
|
1.150
|
1.210
|
1.260
|
1.280
|
1.300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-11-10
|
23-02-22
|
23-05-03
|
23-08-08
|
23-11-07
|
24-02-21
|
24-05-08
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
154
|
-
|
-
|
-
|
Net Cash position
|
427
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
654
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.6%
|
7.9%
|
-
|
9.55%
|
11.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
1.2%
|
1.19%
|
Assets
1 |
-
|
-
|
-
|
46,667
|
54,370
|
Book Value Per Share
2 |
-
|
14.40
|
-
|
27.50
|
31.70
|
Cash Flow per Share
|
-
|
27.60
|
-
|
-
|
-
|
Capex
|
-
|
32
|
-
|
-
|
-
|
Capex / Sales
|
-
|
1.37%
|
-
|
-
|
-
|
Announcement Date
|
20-02-26
|
23-02-22
|
24-02-21
|
-
|
-
|
Last Close Price
42.32
USD Average target price
43
USD Spread / Average Target +1.61% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.00% | 5.34B | | +15.43% | 81.01B | | +9.77% | 51.62B | | +6.17% | 49.77B | | +22.95% | 47.37B | | +13.62% | 42.31B | | +22.53% | 39.55B | | +1.73% | 29.77B | | -1.92% | 29.41B | | -10.44% | 27.79B |
Other Life & Health Insurance
|